Cordlife's Hong Kong and Malaysia Units Receive AABB Reaccreditations
Cordlife's Hong Kong and Malaysia Units Receive AABB Reaccreditations
Additionally, StemLife has also completed ISO 9001:2015 assessment and recertification in June 2024.StemLife has also completed ISO 9001:2015 assessment and recertification in June 2024.
康盛人生也於2024年6月完成了ISO9001:2015評估和重新認證。
Cordlife Group Limited has announced that its subsidiaries in Hong Kong and Malaysia have received reaccreditations from the Association for the Advancement of Blood & Biotherapies (AABB).
康盛人生集團宣佈其在香港和馬來西亞的子公司獲得了血液與生物療法進步協會（AABB）的再授權。
Cordlife (Hong Kong) Limited achieved its seventh consecutive reaccreditation and Malaysia-based StemLife Berhad (Stemlife) secured its fourth consecutive reaccreditation.
康盛人生（香港）有限公司連續第七次獲得再認證，總部位於馬來西亞的康盛細胞股份有限公司（Stemlife）也獲得了第四次再認證。
Additionally, StemLife has also completed ISO 9001:2015 assessment and recertification in June 2024.
此外，康盛細胞股份有限公司於2024年6月還完成了ISO9001:2015的評估和重新認證。
The company has also expanded its services to include peripheral blood stem cell banking in partnership with Loh Guan Lye Specialists Centre and has begun banking cGMP-certified mesenchymal stem cells (MSCs) from umbilical cords through a partnership with Medixcell Laboratory Sdn Bhd.
該公司還與Loh Guan Lye Specialists Centre合作，擴展了其服務範圍，包括外周血幹細胞銀行，並已通過與Medixcell Laboratory Sdn Bhd的合作開始儲存cGMP認證的臍帶間充質幹細胞（MSCs)。
Meanwhile, Cordlife Philippines also recently opened a new clinical diagnostics laboratory, licensed by the Department of Health, as part of its 15th anniversary celebrations. This new facility will provide a range of diagnostic tests and prenatal screenings.
與此同時，康盛人生菲律賓分公司也在其15週年慶典之際新開了一家由衛生部認證的臨床診斷實驗室。這個新設施將提供一系列的診斷測試和產前篩查。
"Our overseas operations remain robust, as we stay committed to delivering innovative services that cater to a broad base of customers across generations," said Ivan Yiu, group CEO of Cordlife Group Limited, said.
“我們的境外運營情況仍然強勁，因爲我們致力於提供面向各個年代的創新服務，以迎合廣泛的客戶群，” 康盛人生集團首席執行官丘恩澤說。
"In line with our expansion strategy, we will continue to form strategic partnerships and collaborations to further strengthen our market position and capitalise on growth opportunities," he added.
“與我們的擴張策略一致，我們將繼續形成戰略伙伴關係和合作，進一步加強我們的市場地位和利用增長機遇，”他補充道。
